Buten Matthew
- SEC CIK
- 0001898799
No open-market purchases or sales filed in the past year.
Current role at each company
- BHVN Biohaven Ltd.Chief Financial Officeras of Mar 3, 2026
- Biohaven Pharmaceutical Holding Co Ltd.Chief Financial Officeras of Oct 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Buten Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BHVN Biohaven Ltd.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 (view filing) | Oct 5 | 1 day | Buten MatthewChief Financial Officer | PPurchase | +22.7K | $22.00 | +$500.0K | +13.6%189.4K after | |
| Oct 26, 2022 (view filing) | Oct 25 | 1 day | Buten MatthewChief Financial Officer | PPurchase | +142.9K | $10.50 | +$1.50M | +600.3%166.7K after |